JAMA Cardiology

Article	Citations
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China	2975
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)	2866
Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)	1590
Potential Effects of Coronaviruses on the Cardiovascular System	1323
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)	1294
Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes	672
Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases	634
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)	500
Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality	426
Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China	408
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military	403
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)	302
Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination	238
Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection	238
Characteristics Associated With Out-of-Hospital Cardiac Arrests and Resuscitations During the Novel Coronavirus Disease 2019 Pandemic in New York City	215
Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening	204
Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection	194
Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Car	190
Utility of a Deep-Learning Algorithm to Guide Novices to Acquire Echocardiograms for Limited Diagnostic Use	180
A Game Plan for the Resumption of Sport and Exercise After Coronavirus Disease 2019 (COVID-19) Infection	165
Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers	162
The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease	157
Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging	157
Coronavirus Disease 2019 and the Athletic Heart	152
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome	145

Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019	142
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019	139
Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children	138
TET2-Driven Clonal Hematopoiesis and Response to Canakinumab	137
Simultaneous or Rapid Sequence Initiation of Quadruple Medical Therapy for Heart Failure—Optimizing Therapy With the Need for Speed	136
Evolving Trends in Adult Heart Transplant With the 2018 Heart Allocation Policy Change	128
Time to Clinical Benefit of Dapagliflozin and Significance of Prior Heart Failure Hospitalization in Patients With Heart Failure With Reduced Ejection Fraction	128
Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease in the Absence of Risk Factors	128
Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction	127
Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia	127
Use of Machine Learning Models to Predict Death After Acute Myocardial Infarction	126
SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents	126
Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis	123
Outcomes for Out-of-Hospital Cardiac Arrest in the United States During the Coronavirus Disease 2019 Pandemic	114
One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart Valve	112
Screening for Atrial Fibrillation in the Older Population	111
Association of Adverse Childhood Experiences With Cardiovascular Disease Later in Life	109
Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction	106
Lipoprotein(a) and its Significance in Cardiovascular Disease	104
National Trends in Heart Failure Hospitalizations and Readmissions From 2010 to 2017	103
Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic	103
Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia	100
Development of Persistent Opioid Use After Cardiac Surgery	97
Mechanical Complications of Acute Myocardial Infarction	97
Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US	92
Association of Lipid, Inflammatory, and Metabolic Biomarkers With Age at Onset for Incident Coronary Heart Disease in Women	90
Volume-Outcome Association of Mitral Valve Surgery in the United States	89
Association of Optimal Implementation of Sodium-Glucose Cotransporter 2 Inhibitor Therapy With Outcome for Patients With Heart Failure	87
Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine–Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis	86
Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure	86
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction	85
Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines	83
Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial	83
Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations	83
Association of Low Socioeconomic Status With Premature Coronary Heart Disease in US Adults	82
Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes	80
Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events	79
High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy With Cardiovascular Deep Learning	78
Use of Artificial Intelligence and Deep Neural Networks in Evaluation of Patients With Electrocardiographically Concealed Long QT Syndrome From the Surface 12-Lead Electrocardiogram	77
Multichannel Electrocardiograms Obtained by a Smartwatch for the Diagnosis of ST-Segment Changes	77
Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction	77
Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction	77
Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation	74
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor–Associated Myocarditis	74
Posttraumatic Stress Disorder and Cardiovascular Disease	73
Association of Statin Treatment With Progression of Coronary Atherosclerotic Plaque Composition	73
Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction	72
Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction	72
An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic—COVID-19 and Cardiovascular Diseases	71
Remote Optimization of Guideline-Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction	71

Performance of a Convolutional Neural Network and Explainability Technique for 12-Lead Electrocardiogram Interpretation	71
Association of Adverse Pregnancy Outcomes With Risk of Atherosclerotic Cardiovascular Disease in Postmenopausal Women	71
Early Mortality in Type A Acute Aortic Dissection	69
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease	66
Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure	66
Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease	66
Effectiveness of Home-Based Mobile Guided Cardiac Rehabilitation as Alternative Strategy for Nonparticipation in Clinic-Based Cardiac Rehabilitation Among Elderly Patients in Europe	64
Coronary Angiography After Cardiac Arrest Without ST Segment Elevation	63
Identification of Susceptibility Loci for Spontaneous Coronary Artery Dissection	62
Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction	61
Association Between Preterm Birth and Arrested Cardiac Growth in Adolescents and Young Adults	61
Short-term and Long-term Feasibility, Safety, and Efficacy of High-Intensity Interval Training in Cardiac Rehabilitation	60
Assessment of Neutrophil Extracellular Traps in Coronary Thrombus of a Case Series of Patients With COVID-19 and Myocardial Infarction	59
Association of Age With the Diagnostic Value of Coronary Artery Calcium Score for Ruling Out Coronary Stenosis in Symptomatic Patients	59
Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease	58
Interpretation of the Seattle Angina Questionnaire as an Outcome Measure in Clinical Trials and Clinical Care	58
Survival on the Heart Transplant Waiting List	58
Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) Pandemic	58
Contemporaneous Comparison of Outcomes Among Patients Implanted With a Leadless vs Transvenous Single-Chamber Ventricular Pacemaker	57
Clinical Utility of Lipoprotein(a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease	57
Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy	55
Stress Myocardial Perfusion Imaging vs Coronary Computed Tomographic Angiography for Diagnosis of Invasive Vessel-Specific Coronary Physiology	55
Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation	55
Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea	55
Sex Differences in Procedural Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion	54
Coronavirus Disease 2019 (COVID-19) and the Heart—Is Heart Failure the Next Chapter?	54
Temporal Association Between Episodes of Atrial Fibrillation and Risk of Ischemic Stroke	53
Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk	53
Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients	53
Fundamental Pathobiology of Coronary Atherosclerosis and Clinical Implications for Chronic Ischemic Heart Disease Management—The Plaque Hypothesis	51
Association of Effective Regurgitation Orifice Area to Left Ventricular End-Diastolic Volume Ratio With Transcatheter Mitral Valve Repair Outcomes	51
Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event	51
Interventions to Mitigate Risk of Cardiovascular Disease After Adverse Pregnancy Outcomes	51
Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome	50
Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors	50
Magnetic Resonance Imaging in Patients With Cardiac Implantable Electronic Devices With Abandoned Leads	50
Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Hear	49
Effect of Exercise Training on Ambulatory Blood Pressure Among Patients With Resistant Hypertension	49
Emergency vs Delayed Coronary Angiogram in Survivors of Out-of-Hospital Cardiac Arrest	49
Association of Diet Quality With Prevalence of Clonal Hematopoiesis and Adverse Cardiovascular Events	48
Long-term Results of Differentiated Anatomic Reconstruction of Bicuspid Aortic Valves	47
Efficacy of Telmisartan to Slow Growth of Small Abdominal Aortic Aneurysms	46
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High–risk Pulmonary Embolism	46
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	45
Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction	45
Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction	44
Combined Cardiac Fluorodeoxyglucose–Positron Emission Tomography/Magnetic Resonance Imaging Assessment of Myocardial Injury in Patients Who Recently Recovered From COVID-19	43
Association Between Malignant Mitral Valve Prolapse and Sudden Cardiac Death	42
Racial, Ethnic, and Socioeconomic Disparities in Access to Transcatheter Aortic Valve Replacement Within Major Metropolitan Areas	42
Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation in Patients at Intermediate or High Risk	42
Differences in Long-term Outcomes After Coronary Artery Bypass Grafting Using Single vs Multiple Arterial Grafts and the Association With Sex	42
Assessing the Role of Rare Genetic Variation in Patients With Heart Failure	41
Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart Failure	41
Skeletonized vs Pedicled Internal Mammary Artery Graft Harvesting in Coronary Artery Bypass Surgery	41
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy	39
Association of Socioeconomic Disadvantage With Long-term Mortality After Myocardial Infarction	39
Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the US	38
Association of Sitting Time With Mortality and Cardiovascular Events in High-Income, Middle-Income, and Low-Income Countries	38
Association of Damaging Variants in Genes With Increased Cancer Risk Among Patients With Congenital Heart Disease	37
Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	37
Natural History of Asymptomatic Severe Aortic Stenosis and the Association of Early Intervention With Outcomes	37
Association Between Visit-to-Visit Blood Pressure Variability in Early Adulthood and Myocardial Structure and Function in Later Life	37
Association Between Reproductive Life Span and Incident Nonfatal Cardiovascular Disease	36
Association of Circulating Monocyte Chemoattractant Protein–1 Levels With Cardiovascular Mortality	36
Apolipoprotein B vs Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol as the Primary Measure of Apolipoprotein B Lipoprotein-Related Risk	35
Association of Rare Genetic Variants and Early-Onset Atrial Fibrillation in Ethnic Minority Individuals	35
Results of a Remotely Delivered Hypertension and Lipid Program in More Than 10 000 Patients Across a Diverse Health Care Network	35
Comparison of Long-term Clinical Outcomes of Skeletonized vs Pedicled Internal Thoracic Artery Harvesting Techniques in the Arterial Revascularization Trial	35
Clinical and Functional Characterization of Ryanodine Receptor 2 Variants Implicated in Calcium-Release Deficiency Syndrome	34
Association of Posttraumatic Stress Disorder and Incident Ischemic Heart Disease in Women Veterans	34
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers	34
Demographic and Regional Trends of Heart Failure–Related Mortality in Young Adults in the US, 1999-2019	34
The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk Factor	33
Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure	33
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control	33
Trends in the Prevalence of Self-reported Heart Failure by Race/Ethnicity and Age From 2001 to 2016	32
Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials	32
Association of Differences in Treatment Intensification, Missed Visits, and Scheduled Follow-up Interval With Racial or Ethnic Disparities in Blood Pressure Control	32
Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases	32
Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary Prevention	32

Individualized Studies of Triggers of Paroxysmal Atrial Fibrillation	32
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention	31
Association of Echocardiographic Left Ventricular End-Systolic Volume and Volume-Derived Ejection Fraction With Outcome in Asymptomatic Chronic Aortic Regurgitation	31
Objective Risk Assessment vs Standard Care for Acute Coronary Syndromes	31
Association of Pediatric Obstructive Sleep Apnea With Elevated Blood Pressure and Orthostatic Hypertension in Adolescence	31
Assessment of the Diagnostic Yield of Combined Cardiomyopathy and Arrhythmia Genetic Testing	31
A Simple Score to Identify Increased Risk of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction	30
Association of Atrial Fibrillation Burden With Health-Related Quality of Life After Atrial Fibrillation Ablation	30
Hybrid Positron Emission Tomography/Magnetic Resonance Imaging in Arrhythmic Mitral Valve Prolapse	30
Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy	30
Exercise Electrocardiography and Computed Tomography Coronary Angiography for Patients With Suspected Stable Angina Pectoris	30
Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines	30
Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis	30
Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction	29
Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes	29
Derivation and Validation of a 4-Level Clinical Pretest Probability Score for Suspected Pulmonary Embolism to Safely Decrease Imaging Testing	29
Guideline Update on Indications for Transcatheter Aortic Valve Implantation Based on the 2020 American College of Cardiology/American Heart Association Guidelines for Management of Valvular Heart Dise	28
Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines	28
Efficacy and Safety of Dapagliflozin in Men and Women With Heart Failure With Reduced Ejection Fraction	28
Associations of High-Sensitivity Troponin and Natriuretic Peptide Levels With Outcomes After Intensive Blood Pressure Lowering	28
Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis	28
Genomic Autopsy of Sudden Deaths in Young Individuals	28
Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure	28
Long-term Benefits and Harms Associated With Genetic Cholesteryl Ester Transfer Protein Deficiency in the General Population	28
Association of Systolic Blood Pressure Elevation With Disproportionate Left Ventricular Remodeling in Very Preterm-Born Young Adults	27
Trends in Readmission and Mortality Rates Following Heart Failure Hospitalization in the Veterans Affairs Health Care System From 2007 to 2017	27
Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease	27
Long-term Survival After Out-of-Hospital Cardiac Arrest	27
State of the Nation’s Cardiovascular Health and Targeting Health Equity in the United States	27
Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials	27
Cardiovascular Biomarkers in the Early Discrimination of Type 2 Myocardial Infarction	26
Long-term Clinical and Echocardiographic Outcomes in Young and Middle-aged Adults Undergoing the Ross Procedure	26
Transcatheter Aortic Valve Replacement in Low-risk Patients With Bicuspid Aortic Valve Stenosis	26
Quality of Life in Patients With Heart Failure With Recovered Ejection Fraction	26
Return to Play for Athletes After COVID-19 Infection	26
Association of Mortality With Aortic Stenosis Severity in Outpatients	25
Routine Ultrasonography Guidance for Femoral Vascular Access for Cardiac Procedures	25
Association of Mitral Annular Disjunction With Cardiovascular Outcomes Among Patients With Marfan Syndrome	25
Blood DNA Methylation and Incident Coronary Heart Disease	25
Genetic Risk Factors Associated With Preeclampsia and Hypertensive Disorders of Pregnancy	25
Association of Non–High-Density Lipoprotein Cholesterol Measured in Adolescence, Young Adulthood, and Mid-Adulthood With Coronary Artery Calcification Measured in Mid-Adulthood	25
Association of Financial Hardship Because of Medical Bills With Adverse Outcomes Among Families of Children With Congenital Heart Disease	25
Association of Rurality With Risk of Heart Failure	25
Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National Biobank	25
Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction	25
Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation	25
Assessment of Artificial Intelligence in Echocardiography Diagnostics in Differentiating Takotsubo Syndrome From Myocardial Infarction	24
Effect of Transcutaneous Magnetic Stimulation in Patients With Ventricular Tachycardia Storm	24
Association of Smoking With Postprocedural Complications Following Open and Endovascular Interventions for Intermittent Claudication	24
Sex and Race Differences in N-Terminal Pro–B-type Natriuretic Peptide Concentration and Absolute Risk of Heart Failure in the Community	24
Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease	24
Evaluation of Stress Cardiac Magnetic Resonance Imaging in Risk Reclassification of Patients With Suspected Coronary Artery Disease	24
Association of Global Longitudinal Strain With Clinical Status and Mortality in Patients With Chronic Heart Failure	24
Remote Cardiac Monitoring in Patients With Heart Failure	23
Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals	23
High-Sensitivity Cardiac Troponin Concentrations at Presentation in Patients With ST-Segment Elevation Myocardial Infarction	23
Association Between Delays in Mechanical Ventilation Initiation and Mortality in Patients With Refractory Cardiogenic Shock	23
Effect of Evolocumab on Type and Size of Subsequent Myocardial Infarction	23
Metabolomic Analysis of Coronary Heart Disease in an African American Cohort From the Jackson Heart Study	23
Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation	23
Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery Dissection	23
Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy	23
Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US	22
Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes	22
Effectiveness of Systematic Echocardiographic Screening for Rheumatic Heart Disease in Nepalese Schoolchildren	22
Association of Left Ventricular Remodeling Assessment by Cardiac Magnetic Resonance With Outcomes in Patients With Chronic Aortic Regurgitation	22
Evaluation of Quality of Care for US Veterans With Recent-Onset Heart Failure With Reduced Ejection Fraction	22
Role of Coronary Artery Calcium Testing for Risk Assessment in Primary Prevention of Atherosclerotic Cardiovascular Disease	22
Fibrillar Collagen Variants in Spontaneous Coronary Artery Dissection	22
Association of Genetic West African Ancestry, Blood Pressure Response to Therapy, and Cardiovascular Risk Among Self-reported Black Individuals in the Systolic Blood Pressure Reduction Intervention Tr	22
Fear of Coronavirus Disease 2019—An Emerging Cardiac Risk	22
Preterm Delivery and Long-term Risk of Hypertension in Women	21
Initial Experience Prescribing Commercial Tafamidis, the Most Expensive Cardiac Medication in History	21
Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure	21
Potential Implications of Expanded US Food and Drug Administration Labeling for Sacubitril/Valsartan in the US	21
Feasibility of Remote Video Assessment of Jugular Venous Pressure and Implications for Telehealth	21
Exercise Capacity in Young Adults Born Small for Gestational Age	21
Skeletal Muscle Mitochondrial Respiration and Exercise Intolerance in Patients With Heart Failure With Preserved Ejection Fraction	20
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction	20
Effect of Goal-Setting Approaches Within a Gamification Intervention to Increase Physical Activity Among Economically Disadvantaged Adults at Elevated Risk for Major Adverse Cardiovascular Events	20
Food Insecurity Among Individuals With Cardiovascular Disease and Cardiometabolic Risk Factors Across Race and Ethnicity in 1999-2018	20
Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice	20
Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation	20
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants	19
Association of Titin Variations With Late-Onset Dilated Cardiomyopathy	19
Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing	19
Effect of Smartphone Dispatch of Volunteer Responders on Automated External Defibrillators and Out-of-Hospital Cardiac Arrests	19
Effects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption	19
Genetic Inhibition ofPCSK9and Liver Function	18
A Combined Echocardiography Approach for the Diagnosis of Cancer Therapy–Related Cardiac Dysfunction in Women With Early-Stage Breast Cancer	18
Potential Role and Limitations of Estimated Glomerular Filtration Rate Slope Assessment in Cardiovascular Trials	18
Association of Prior Left Ventricular Ejection Fraction With Clinical Outcomes in Patients With Heart Failure With Midrange Ejection Fraction	18
Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Known Coronary Artery Disease	18
Association of Myocardial Blood Flow Reserve With Adverse Left Ventricular Remodeling in Patients With Aortic Stenosis	18
Sex Differences in Atrial Fibrillation Risk	18